NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

大麻醫藥品市場調查報告:各品牌(Epidiolex,Sativex)-至2025年的預測-COVID-19累積性影響

Cannabis Pharmaceuticals Market Research Report by Brand (Epidiolex and Sativex), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1000988
出版日期 內容資訊 英文 184 Pages
商品交期: 最快1-2個工作天內
價格
大麻醫藥品市場調查報告:各品牌(Epidiolex,Sativex)-至2025年的預測-COVID-19累積性影響 Cannabis Pharmaceuticals Market Research Report by Brand (Epidiolex and Sativex), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 184 Pages
簡介

全球大麻醫藥品的市場規模,預計從2020年的8億7,257萬美元,到2025年末成長為19億7,267萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供大麻醫藥品市場相關調查,市場概要,以及各品牌,各地區的趨勢,COVID-19累積性影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各品牌預測
  • 各地區預測
  • 其他各競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積性影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球大麻醫藥品市場,各品牌

  • Epidiolex
  • Sativex

第7章 南北美洲的大麻醫藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第8章 亞太地區的大麻醫藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第9章 歐洲,中東、非洲的大麻醫藥品市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第10章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第11章 企業的實用性簡介

  • AbbVie Inc.
  • Amyris, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Botanix Pharmaceuticals
  • Breath of Life Pharma, Ltd.
  • Cannabis Science, Inc.
  • Canopy Growth Corporation
  • Cara Therapeutics
  • CB Therapeutics Inc.
  • Corbus Pharmaceuticals Holdings, Inc.
  • Cronos Group Inc.
  • GW Pharmaceuticals, PLC
  • Insys Therapeutics, Inc.
  • Medical Marijuana Inc.
  • Medicure Pharmaceuticals
  • MedReleaf Corp.
  • MGC Pharmaceuticals Limited
  • Pascal Biosciences Inc.
  • PharmaCyte Biotech, Inc.
  • Serina Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tilray, Inc.
  • Valeant Pharmaceuticals
  • Zynerba Pharmaceuticals, Inc.

第12章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-221461476B57

The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 Million in 2020 and expected to reach USD 1,031.56 Million in 2021, at a Compound Annual Growth Rate (CAGR) 18.55% to reach USD 2,423.25 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cannabis Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Brand , the Cannabis Pharmaceuticals Market was studied across Epidiolex and Sativex.

Based on Geography, the Cannabis Pharmaceuticals Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabis Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cannabis Pharmaceuticals Market, including AbbVie Inc., Amyris, Inc., Aphria, Inc., Aurora Cannabis, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Canopy Growth Corporation, Cara Therapeutics, CB Therapeutics Inc., Corbus Pharmaceuticals Holdings, Inc., Cronos Group Inc., GW Pharmaceuticals, PLC, Insys Therapeutics, Inc., Medical Marijuana Inc., Medicure Pharmaceuticals, MedReleaf Corp., MGC Pharmaceuticals Limited, Pascal Biosciences Inc., PharmaCyte Biotech, Inc., Serina Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Tilray, Inc., Valeant Pharmaceuticals, and Zynerba Pharmaceuticals, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cannabis Pharmaceuticals Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabis Pharmaceuticals Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabis Pharmaceuticals Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cannabis Pharmaceuticals Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cannabis Pharmaceuticals Market?
  • 6. What is the market share of the leading vendors in the Global Cannabis Pharmaceuticals Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cannabis Pharmaceuticals Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Brand Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the legalization of medicinal cannabis in economies
      • 5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
      • 5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others
    • 5.1.2. Restraints
      • 5.1.2.1. High price associated with the medical cannabis
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in investments by pharma companies in CBD and developments for cannabinoid regulation
      • 5.1.3.2. Innovation and launching new products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of various alternatives in the market
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Cannabis Pharmaceuticals Market, by Brand

  • 6.1. Introduction
  • 6.2. Epidiolex
  • 6.3. Sativex

7. Americas Cannabis Pharmaceuticals Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Cannabis Pharmaceuticals Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Cannabis Pharmaceuticals Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. AbbVie Inc.
  • 11.2. Amyris, Inc.
  • 11.3. Aphria, Inc.
  • 11.4. Aurora Cannabis, Inc.
  • 11.5. Botanix Pharmaceuticals
  • 11.6. Breath of Life Pharma, Ltd.
  • 11.7. Cannabis Science, Inc.
  • 11.8. Canopy Growth Corporation
  • 11.9. Cara Therapeutics
  • 11.10. CB Therapeutics Inc.
  • 11.11. Corbus Pharmaceuticals Holdings, Inc.
  • 11.12. Cronos Group Inc.
  • 11.13. GW Pharmaceuticals, PLC
  • 11.14. Insys Therapeutics, Inc.
  • 11.15. Medical Marijuana Inc.
  • 11.16. Medicure Pharmaceuticals
  • 11.17. MedReleaf Corp.
  • 11.18. MGC Pharmaceuticals Limited
  • 11.19. Pascal Biosciences Inc.
  • 11.20. PharmaCyte Biotech, Inc.
  • 11.21. Serina Therapeutics, Inc.
  • 11.22. Teva Pharmaceutical Industries Ltd.
  • 11.23. Tilray, Inc.
  • 11.24. Valeant Pharmaceuticals
  • 11.25. Zynerba Pharmaceuticals, Inc.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2020 (USD MILLION)
  • FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2026
  • FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 14. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 16. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 17. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 18. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 19. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 20. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 21. CALIFORNIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 22. FLORIDA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 23. ILLINOIS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 24. NEW YORK CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 25. OHIO CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 26. PENNSYLVANIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. TEXAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 29. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 31. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 40. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 42. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. GLOBAL CANNABIS PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 54. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 55. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CANNABIS PHARMACEUTICALS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. CALIFORNIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. FLORIDA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ILLINOIS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. NEW YORK CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. OHIO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. PENNSYLVANIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. TEXAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SCORES
  • TABLE 45. GLOBAL CANNABIS PHARMACEUTICALS MARKET: BUSINESS STRATEGY
  • TABLE 46. GLOBAL CANNABIS PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
  • TABLE 47. GLOBAL CANNABIS PHARMACEUTICALS MARKET: RANKING
  • TABLE 48. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 49. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 50. GLOBAL CANNABIS PHARMACEUTICALS MARKET: MERGER & ACQUISITION
  • TABLE 51. GLOBAL CANNABIS PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 52. GLOBAL CANNABIS PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 53. GLOBAL CANNABIS PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
  • TABLE 54. GLOBAL CANNABIS PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 55. GLOBAL CANNABIS PHARMACEUTICALS MARKET: LICENSE & PRICING
  • TABLE 56. GLOBAL CANNABIS PHARMACEUTICALS MARKET: CONTACT DETAILS